EV/EBITDA
-7.37
+0.08+1.07%
10 min ago
Summary
- As of March 12, 2025, CADL EV/EBITDA is -7.37, with a rise of +0.08 (+1.07%) during the most recent trading day.
- CADL EV/EBITDA is now -2147.22% below its all-time high of 0.36.
Performance
CADL EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
CADL EV/EBITDA Trends
PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
---|---|---|---|
todaytoday | +1.1% | -1.1% | -1.1% |
1 m1 month | +6.8% | -6.9% | -6.9% |
3 m3 months | -56.8% | +56.6% | +14.3% |
6 m6 months | -65.3% | +73.6% | +23.7% |
ytdytd | +7.1% | -7.1% | -7.1% |
1 y1 year | - | +752.2% | +403.1% |
5 y5 years | - | - | - |
CADL EV/EBITDA Highs & Lows
PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
---|---|---|---|---|---|
1 m | 1-month | -2.6% | -11.14 | +33.8% | |
3 m | 3-month | -4.46 | -65.3% | -11.14 | +33.8% |
6 m | 6-month | -2.62 | -181.3% | -11.14 | +33.8% |
1 y | 1-year | -1.33 | -454.1% | -12.79 | +42.4% |
3 y | 3-year | 0.36 | -2147.2% | -12.79 | +42.4% |
5 y | 5-year | 0.36 | -2147.2% | -16.88 | +56.3% |
alltime | all time | 0.36 | -2147.2% | -16.88 | +56.3% |
Candel Therapeutics EV/EBITDA History
Date | Value |
---|---|
2025 | -7.37(-7.1%) |
2024 | -7.93(+844.0%) |
Date | Value |
---|---|
2023 | -0.84(+546.2%) |
2022 | -0.13(-97.8%) |
2021 | -5.83 |
FAQ
- What is Candel Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Candel Therapeutics?
- What is CADL EV/EBITDA year-to-date change?
What is Candel Therapeutics EV/EBITDA?
The current EV/EBITDA of CADL is -7.37
What is the all time high EV/EBITDA for Candel Therapeutics?
Candel Therapeutics all-time high EV/EBITDA is 0.36
What is CADL EV/EBITDA year-to-date change?
Candel Therapeutics EV/EBITDA has changed by +0.56 (+7.06%) since the beginning of the year